Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2018-04-18 · Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS) · Notices

Notices. Request for comments on proposed substances to be evaluated for Toxicological Profile development

717 words·~3 min read·/register/2018/04/18/2018-08090·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease Registry [Docket No. ATSDR-2018-0003] Proposed Substances To Be Evaluated for Toxicological Profile Development AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). ACTION: Request for comments on proposed substances to be evaluated for Toxicological Profile development. SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR) within the Department of Health and Human Services is initiating the development of another set of Toxicological Profiles.
This notice solicits public nominations of substances for ATSDR to evaluate for Toxicological Profile development. ATSDR will consider nominations from the Substance Priority List, as well as any non-Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERLA) substances that may have public health implications, on the basis of ATSDR's authority to prepare Toxicological Profiles for substances not found at sites on the National Priorities List. The agency will do so in order to “. . . establish and maintain inventory of literature, research, and studies on the health effects of toxic substances”, to respond to requests for consultation, and to support the site-specific response actions conducted by ATSDR, as otherwise necessary.
DATES: Nominations from the Substance Priority List and/or additional substances must be submitted by May 18, 2018. ADDRESSES: You may submit nominations, identified by Docket No. ATSDR-2018-0003 by any of the following methods: • *Internet:* Access the Federal eRulemaking portal at *www.regulations.gov* . Follow the instructions for submitting comments. • *Mail:* Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd.
NE, MS F-57, Atlanta, GA 30329. Attn: Docket No. ATSDR-2018-0003. *Instructions:* All submissions must include the agency name and docket number for this notice. All relevant comments will be posted without change. This means that no confidential business information or other confidential information should be submitted in response to this notice. Refer to the section *Submission of Nominations* (below) for the specific information required. FOR FURTHER INFORMATION CONTACT: For further information, please contact Susan Z.
Ingber, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, MS F-57, Atlanta, GA 30329, Email: *wng7@cdc.gov* ; phone: 770.488.0605. SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization Act of 1986
(SARA)[42 U.S.C. 9601 *et seq.* ] amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 U.S.C. 9601 *et seq.* ] by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency
(EPA)with regard to hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare Toxicological Profiles for each substance included on the Priority List of Hazardous Substances. This list identifies 275 hazardous substances that ATSDR and EPA have determined pose the most significant current potential threat to human health. Substances To Be Evaluated for Toxicological Profile Development Each year, ATSDR develops a list of substances to be considered for Toxicological Profile development. The nomination process includes consideration of all substances on ATSDR's Substance Priority List (SPL), as well as other substances nominated by the public. The SPL may be found at the following website: *www.atsdr.cdc.gov/SPL* . Submission of Nominations for Toxicological Profile Development Today's notice invites voluntary public nominations for substances included on the SPL and for substances not listed on the SPL. All nominations should include the full name of the nominator, affiliation, and email address. When nominating a non-SPL substance, please include the rationale for the nomination. Please note that email addresses will not be posted on *regulations.gov* . ATSDR will evaluate data and information associated with nominated substances and will determine the final list of substances to be chosen for Toxicological Profile development. Substances will be chosen according to ATSDR's specific guidelines for selection. These guidelines can be found in the *Selection Criteria,* which may be accessed at *www.atsdr.cdc.gov/toxprofiles/guidance/ATSDR_TP_Selection%20Criteria.pdf* . Please ensure that your comments are submitted within the specified nomination period. Nominations received after the closing date will be marked as late and may be considered only if time and resources permit. Pamela Protzel Berman, Director, Office of Policy, Planning and Partnerships, Agency for Toxic Substances and Disease Registry. [FR Doc. 2018-08090 Filed 4-17-18; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
Request for comments on proposed substances to be evaluated for Toxicological Profile development
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.